Author:
Bheemanapally Khaggeswar,Ibrahim Mostafa M. H.,Briski Karen P.
Abstract
AbstractGlutamine (Gln) is converted to excitatory (glutamate, aspartate) and inhibitory (γ-amino butyric acid) amino acid neurotransmitters in brain, and is a source of energy during glucose deprivation. Current research utilized an Analytical Quality by Design approach to optimize levels and combinations of critical gas pressure (sheath, auxiliary, sweep) and temperature (ion transfer tube, vaporizer) parameters for high-sensitivity mass spectrometric quantification of brain tissue glutamine. A Design of Experiments (DOE) matrix for evaluation of relationships between these multiple independent variables and a singular response variable, e.g. glutamine chromatogram area, was developed by statistical response surface methodology using central composite design. A second-order polynomial equation was generated to identify and predict singular versus combinatory effects of synergistic and antagonistic factors on chromatograph area. Predicted versus found outcomes overlapped, with enhanced area associated with the latter. DOE methodology was subsequently used to evaluate liquid chromatographic variable effects, e.g. flow rate, column temperature, and mobile phase composition on the response variable. Results demonstrate that combinatory AQbD-guided mass spectrometric/liquid chromatographic optimization significantly enhanced analytical sensitivity for Gln, thus enabling down-sized brain tissue sample volume procurement for quantification of this critical amino acid.
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Reid, G. L., et al. Analytical Quality by Design (AQbD) in pharmaceutical development, Amer. Pharmaceut. Rev. ttps://www.americanpharmaceuticalreview.com/Featured-Articles/144191-Analytical-Quality-by-Design-AQbD-in-Pharmaceutical-Development/ (2013).
2. Kochling, J., Wu, W., Hua, Y., Guan, Q. & Castaneda-Merced, J. A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC–MS methods development for protein analysis. J. Pharmaceut. Biomed. Anal. 125, 130–139 (2016).
3. Hecht, E. S., Oberg, A. L. & Muddiman, D. C. Optimizing mass spectrometry analyses: a tailored review on the utility of design of experiments. J. Amer. Soc. Mass Spectrometry 27, 767–785 (2016).
4. Kourti, T. Pharmaceutical manufacturing: the role of multivariate analysis in design space, control strategy, process understanding, troubleshooting, and optimization. Chem. Eng. Pharmaceut. Ind.: Drug Prod. Design. Develop. Model. 29, 601–629 (2019).
5. T.Kourti, et al. Scientific and regulatory considerations for implementing mathematical models in the quality by design (QbD) framework, Pharm Eng. 34(6) (2014).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献